QUICK POLL
What percentage of new treatments tested in NCI-funded phase III randomized controlled trials from 1995 to 2000 were successful compared to standard treatment?
2nd Asian Pacific Conference: Perspectives in Lung Cancer
1 - 2 August 2008
Sapporo, Hokkaido, Japan
Sheraton Sapporo Hotel
CONTINUING MEDICAL EDUCATION
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum 13.5 of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
LEARNING OBJECTIVES
After successful completion of this continuing medical education activity, participants should be able to:
- Describe the epidemiology of lung cancer and emerging screening techniques
- Evaluate the role of surgery, radiotherapy, and chemotherapy in the treatment of early-stage lung cancer
- Compare and contrast computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and invasive procedures in the staging of lung cancer
- Discuss the emerging role of targeted therapies in the treatment of lung cancer and optimal strategies for patient selection
- Analyze the current lung cancer research techniques and methodology utilized throughout Asia
- Describe recent advances in the management of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC)
Hirotoshi Akita, MD, PhD Hisao Asamura, MD Alex Chang, MD John Crowley, PhD Masahiro Fukuoka, MD Pasi A. Janne, MD, PhD James R. Jett, MD Guo-Liang Jiang, MD, FACR Ryutaro Kakinuma, MD Kaoru Kubota, MD, PhD Hideo Kunitoh, MD |
Shun Lu, MD Tetsuya Mitsudomi, MD Tony Mok, MD Yasushi Nagata, MD, PhD Kazuhiko Nakgawa, MD Masakazu Nakamura, MD Kazuto Nishio, MD, PhD Yuichiro Ohe, MD Purvish Parikh, MD, PhD Keunchil Park, MD |
Nagahiro Saijo, MD, PhD Giorgio V. Scagliotti, MD, PhD Takashi Takahashi, MD Tomohide Tamura, MD Sumitra Thongprasert, MD Chun-Ming Tsai, MD Masahiro Tsuboi, MD Yi-Long Wu, MD James Chih-Hsin Yang, MD, PhD Li Zhang, MD |
Friday, 1 August 2008
Session I: State-of-the-art lectures 1
Moderators: Tony Mok, MD and
Nagahiro Saijo, MD, PhD
8:30
Global tobacco control strategy and its impact in Asia
Speaker Invited
9:00
Epidemiology of tobacco addiction
Masakazu Nakamura, MD
9:15
Smoking cessation methodology
Speaker Invited
9:35
Early detection strategies: High resolution CT and emerging technology
Western perspective: James R. Jett, MD
Japanese perspective: Ryutaro Kakinuma, MD
10:35
Coffee break
11:00
Surgical and non-surgical treatment of early stage disease
Hisao Asamura, MD
11:30
Role of RT in early stage disease
Yasushi Nagata, MD, PhD
12:00
Systemic therapy in early NSCLC
Giorgio V. Scagliotti, MD, PhD
12:30
Discussion
13:00
Lunch break
Session II: Keynote Lecture
14:00
Targeted therapies: State-of-the-art
Pasi A. Janne, MD, PhD
Session III: Interactive case presentations
Moderators: Hideo Kunitoh, MD and Tony Mok, MD
14:45
Interactive case presentations
Facilitators: Masahiro Fukuoka, MD and Nagahiro Saijo, MD, PhD
Case 1: Kaoru Kubota, MD, PhD
Case 2: Purvish Parikh, MD, PhD
Case 3: James Chih-Hsin Yang, MD, PhD
16:00
Coffee break
Session IV: Lung cancer research methodology
Moderators: Yuichiro Ohe, MD and Yi-Long Wu, MD
16:30
Biostatistics that a clinician should know
John Crowley, PhD
16:45
How to get published in an international journal
James R. Jett, MD
17:00
Lung cancer study groups and research plan in Asia
Yi-Long Wu, MD
17:15
Lung cancer study groups and research plan in Japan
Kazuhiko Nakagawa, MD
17:30
Lung cancer study groups and research plan in Korea
Keunchil Park, MD
17:45
Adjourn
Saturday, 2 August 2008
Session V: State-of-the-art lectures 2
Moderators: Masahiro Fukuoka, MD and Giorgio V. Scagliotti, MD, PhD
8:30
Anti-angiogenesis: Current practice and a look into the future
Tony Mok, MD
9:00
Biomarker strategies in patient selection for molecular targeted therapy
Kazuto Nishio, MD, PhD
9:30
How to integrate molecular targeted therapies with chemotherapy
Chun-Ming Tsai, MD
10:00
Coffee break
10:30
How to integrate molecular targeted therapies with radiotherapy
Guo-Liang Jiang, MD, FACR
11:00
Ethnic differences in lung cancer: An emerging issue
Shun Lu, MD
11:30
Discussion
11:45
Lunch break
Session VI: State-of-the-art lectures 3
Moderator: Hirotoshi Akita, MD, PhD
14:00
The long way to a new staging system for lung cancer
James R. Jett, MD
14:30
Invasive and non-invasive assessment of the mediastinal involvement
Masahiro Tsuboi, MD
15:00
Maintenance and sequential therapy for NSCLC
Kaoru Kubota, MD, PhD
15:30
Coffee break
16:00
Personalized therapy of lung cancer using EGFR-TKle
Tetsuya Mitsudomi, MD
16:30
Major developments in small cell lung cancer
Tomohide Tamura, MD
17:00
“Omics Views” of lung cancers
Takashi Takahashi, MD
17:30
Systemic management of bone metastasis
Li Zhang, MD
18:00
Adjourn
REGISTRATION FEES
Regular . . . . . . . . . . . . . . . . . . . .$299.00 USD
(If payment received by 23 July 2008)
Full/Onsite . . . . . . . . . . . . . . . . . .$349.00 USD
(If payment received after 23 July 2008)
Group discount (physicians only)* . . -$50.00 USD
*Cannot be combined with any other discounts
Nurses/Residents/Students . . . . . . . $99.00 USD
*Proof of eligibility must accompany registration
To Register: You may register online by 23 July 2008 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the Congress. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Group Discounts: Each one of registrants from the same institute or practice each receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per physician. Discounts are not available for nurses, residents, and students rate.
Payment: To pre-register, registration and payment must be received no later than 23 July 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. An attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, Congress materials and all event functions as specified in the agenda.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than 23 July 2008. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 23 July 2008.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this Congress should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
Sheraton Sapporo
Hotel
Atsubetsuchuo 2J0, 5 Chome, Atsubetsu-Ku
Sapporo, Hokkaido 0040052, Japan
Tel.: (81) (11) 895 8811
Fax: (81) (11) 895 8820
www.sheraton.com/Sapporo
The Sheraton Sapporo Hotel is conveniently located in the largest city in Hokkaido, with direct access to the train, subway, and bus terminals. Here you can enjoy the energy and excitement of the city along with the spaciousness and freedom of nature.
Located in northern Japan, Hokkaido is a paradise where four distinct seasons create dramatic changes in nature. With such a wonderful backdrop of natural beauty, the seasons present unique pursuits for travelers. In the warmer months, you can tour mountains covered in vivid flowers, see the historical village of Hokkaido, or taste Sapporo’s famous beer. Alternatively, visit Sapporo’s renowned snow festival, marvel at the Okurayama Ski Jump Stadium, or go skiing when the weather turns cold.
For the convenience of attendees, a limited number of rooms have been reserved until 30 June 2008 at a discounted rate of JPY 20,000 for Single Occupancy for Standard Twin, and JPY 22,000 for Double Occupancy for Standard Twin Room, plus tax, currently at 5%. These rates include a daily breakfast buffet. These rates are not guaranteed outside the Congress dates or after 30 June 2008.
To reserve your room please go to: http://www.starwoodmeeting.com/StarGroupsWeb/res?id=0802089045&key=4A078
Reservation requests received after 30 June 2008 may not be guaranteed the group rate.
CHAIRS:
Tony Mok, MD
Chinese University of Hong Kong
Hong Kong, China
Giorgio V. Scagliotti, MD, PhD
University of Turin
Orbassano, Italy
LOCAL CHAIRS:
Masahiro Fukuoka, MD
Kinki University School of Medicine
Osaka, Japan
Nagahiro Saijo, MD, PhD
National Cancer Centre Hospital East
Chiba, Japan
LETTER FROM THE CHAIRS:
Dear Colleague,
It is our pleasure to invite you to The 2nd Asian Pacific Conference: Perspectives in Lung Cancer, 1-2 August 2008 in Sapporo, Hokkaido, Japan. Attendees from all lung cancer-related disciplines will find it to be a stimulating interactive and educational experience.
The 2nd Asian Pacific Conference: Perspectives in Lung Cancer has been created to provide state-of-the-art diagnosis and treatment information. Attendees will update their knowledge in the field, confirm their current practices and receive valuable take-home information on exciting new treatments and approaches. Guided by interactive case presentations, the agenda will feature state-of-the-art discussions focusing on innovations in diagnosis and staging, the latest therapies and techniques in the multidisciplinary management of non-small cell lung cancer and small cell lung cancer, as well as a focus on the trends and evolutions worth watching. Several breakout sessions will provide unique opportunities to discuss topics of special interest.
We hope you will be able to join us for this valuable two day meeting. The fields of lung cancer research and treatment are constantly evolving, and there are many issues in disease biology, management, and research that are intensely debated among those involved in these fields. With expert faculty from Asia, Europe, and North America, and a comprehensive agenda focusing on the multimodal management of lung cancer, we know you will find The 2nd Asian Pacific Conference: Perspectives in Lung Cancer to be a world-class educational event.
We look forward to welcoming you in Sapporo, a marvelous multi-cultural metropolis that harmoniously blends new and old for the comfort of the business traveler and the enjoyment of every visitor.
Sincerely,
Co-Chairs:
Tony Mok, MD
Giorgio V. Scagliotti, MD, PhD
Local Chairs:
Masahiro Fukuoka, MD
Nagahiro Saijo, MD, PhD
DISCOUNTED AIRFARES:
Contact Congress travel agent, Williamsburg Travel, for assistance with your travel needs. Williamsburg Travel can also accommodate pre- and post-Congress extensions.
Tel.: +1 (888) 232-9394 or +1 (770) 261-8613
Email: judit@willtrav.com
ITALIAN PARTICIPANTS:
Fargo International Meetings & Conventions SRL has been appointed as the official agency for government authorization for Italian participants.
You may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078
CONGRESS LOCATION:
Sheraton Sapporo Hotel
Atsubetsuchuo 2J0
5 Chome, Atsubetsu-Ku
Sapporo, Hokkaido 0040052, Japan
Tel.: (81) (11) 895 8811
Fax: (81) (11) 895 8820
Registration Hours:
The Registration and Information
Desk will be staffed:
Friday, 1 August 2008 . . . . . . . . 7:30 – 18:00
Saturday, 2 August 2008 . . . . . . 7:30 – 18:00
ORGANIZER:
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies have provided an unrestricted educational grant in support of this conference:
Bronze Corporate
Donor
Takeda Pharmaceuticals North America, Inc. |
Several options are available to companies interested in supporting this conference. For more information, please contact Imedex at +1 (770) 751 7332, or by email at cme@imedex.com.